Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 14Breast Neoplasms 9Neoplasms 5Lung Neoplasms 5Neuroendocrine Tumors 4Melanoma 4Lymphoma 4Carcinoma, Non-Small-Cell Lung 4Carcinoma, Hepatocellular 4Brain Neoplasms 4Pancreatic Neoplasms 3Head and Neck Neoplasms 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Extranodal NK-T-Cell 2Esophageal Neoplasms 2Central Nervous System Neoplasms 2Waldenstrom Macroglobulinemia 1Vasculitis 1Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Toxemia 1Thrombocythemia, Essential 1Stomach Neoplasms 1Solid Tumor, Adult 1Smoking Cessation 1Sezary Syndrome 1

Interventions

zirconium-89-trastuzumab 1STA 9090 1Positron-Emission Tomography 1Pemetrexed 1Oxaliplatin 1Leucovorin 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Esophagogastric Cancer × Positron-Emission Tomography × Clear all
NCT02023996 2024-12-10

PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer

Memorial Sloan Kettering Cancer Center

Phase NA Completed
42 enrolled 11 charts
Gastrointestinal

Esophagogastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡